Original Paper 419
mean from 3 independent experiments. Camptothecin (Sigma
Aldrich Chimie) was used for comparison as standard drug of cy-
totoxic activity.
Table 1 Hemisynthetic derivativesa
Compounds
R
R1
R2
(+)-Catechin 5-O-gallate (2): 1H-NMR (600 MHz, CD3OD): δ = 7.16
(s, 2H, H2′′, H6′′), 6.81 (d, J = 1.6, H-6′), 6.73 (d, J = 8 Hz, 1H, H-5′),
6.70 (dd, J = 2, 8 Hz, H-2′), 6.23 (d, J = 2.2 Hz, 1H, H-8), 6.20 (d,
J = 2.2 Hz, 1H, H-6), 4.61 (d, J = 7.4 Hz, 1H, H-2), 3.95 (m, 1H, H-
3), 2.72 (dd, J = 8.2, 16 Hz, 1H, H-4b), 2.46 (dd, J = 5.2, 16 Hz, 1H,
H-4a); 13C NMR (150.75 MHz, CD3OD): δ = 166.6 (CO), 158.3 (C-
7), 157.2 (C-9), 151.9 (C-5), 146.9 (C-5′′, C-3′′), 146.5 (C-3′, C-4′),
140.1 (C-4′′), 131.9 (C-1′), 120.4 (C-1′′), 120.1 (C-6′), 116.2 (C-5′),
115.3 (C-2′), 110.7 (C-2′′, C-6′′), 106.6 (C-10), 103.6 (C-6), 101.7
(C-8), 83.2 (C-2), 68.3 (C-3), 28.8 (C-4).
11a
12a
13a
11b
12b
13b
5
H
H
Gp
H
H
Gp
Gp
H
H
Gp
Gp
H
C6H5
C6H5
Gp
Gp
H
C6H5
Gp
Ga
H
–
–
–
–
–
6
Ga
Ga
Ga
Ga
7
Ga
H
8
9
Ga
a
"
●
■
Results and Discussion
!
By bioassay-guided fractionation, four phenolic compounds 1–4
were isolated. Compound 1 was identified as (+)-catechin by
comparison of its spectral data with those published in the liter-
ature [11].
Preparation of compounds 5–9
The analogues of compound 2 were synthesized from commer-
Compound 2 isolated as an amorphous powder exhibited a qua-
si-molecular ion [M + H]+ at m/z = 443 in the ESI-TOF-MS spec-
trum in agreement with the molecular formula C22H18O10. Inter-
pretation of the COSY, HMQC and HMBC spectra demonstrated 2
to be a derivative of catechin 1. The chemical shift pattern of 7
additional 13C signals with reference to compound 1, together
with the presence of the singlet at δ = 7.16 accounting for two
protons, indicated the presence of a galloyl unit in compound 2.
The upfield shift of the C-5 signal and the downfield shift of C-6,
C-8 and C-10 signals with respect to compound 1 strongly sug-
gested that the galloyl moiety was linked to C-5. Long-range cor-
relations between H-6 and H-4 and C-5 were in agreement with
our hypothesis. The typical downfield shifts due to esterification
indicated the position of the carbon linked with the galloyl
group. However, the NMR spectral data of compound 2 were
also similar to those of (+)-catechin7-O-gallate isolated from
Sanguisorba officinalis with inversion at C-5 and C-7 [12]. In this
previous work, the structure was elucidated only by using 1 D
NMR data and chemical modification. To definitively establish
the position of the galloyl group, NMR spectra were performed
in deuterated DMF at 230 K, which, unlike those performed in
DMSO-d6, allowed us to distinguish a free hydroxy group (OH-
3) at δ = 5.69 and three free phenolic hydroxy groups at δ = 9.70,
10.24 and 10.65, respectively. The observation of a correlation
between the phenolic hydroxy group at δ = 10.65 and H-8 in the
NOESY spectrum confirmed its presence in position 7, and sub-
sequently allowed us to assign the galloyl group to position 5.
On the basis of all the above evidence, compound 2 was deter-
mined to be (+)-catechin 5-O-gallate known as (+)-catechin 5-
gallate [13].
"
cially available (+)-catechin (Sigma) as outlined in Fig. ● 2 (and
"
Table ● 1). The catechol function was protected either as the
methylene acetal with bromochloromethane (series a) and pro-
vided 10a in 33% yield, or with the diphenylmethylene ketal
group by treatment of 1 with dichlorodiphenylmethane (series
b) affording 10b in 20% yield [7], [8]. The reagent necessary for
galloylation was obtained from gallic acid by benzylation with
benzyl bromide followed by treatment with oxalyl chloride. Es-
terification of protected catechin (10a, 10b) by tri-O-benzylgal-
loyl chloride in pyridine and in the presence of DMAP gave a
mixture of three compounds for each series, 11, 12, 13, in 10–
17% yields [9]. The separation of these compounds was per-
formed by flash chromatography on silica gel or by MPLC and
the structure of each one was determined by 2 D NMR and MS
analysis. Removal of the benzyl and diphenylmethylene groups
was achieved by hydrogenolysis using 10% palladium on actived
charcoal. Deprotection of 11b gave a derivative of which the
spectral data were identical to those of compound 2. Compounds
5–7 were obtained without need of purification while com-
pounds 8 and 9 had to be purified on Sephadex LH-20 to remove
diphenylmethane generated during the reaction. All final com-
pounds displayed spectral data (NMR, MS) which were consis-
tent with the assigned structures.
In vitro antiplasmodial test
The in vitro antiplasmodial tests, based on the inhibition of [3H]-
hypoxanthine uptake by Plasmodium falciparum cultured in hu-
man blood, were performed as previously described [10]. Chlor-
oquine diphosphate (Sigma Aldrich Chimie SARL) was used as
positive control of the antiplasmodial activity.
Preliminary interpretation of the NMR data of compound 3 indi-
cated that it was an isomer of compound 2 and was a flavonoid
closely related to catechin 1. Thus, when 1H-NMR spectrum of
compound 3 was compared to that of compound 1, there was a
downfield shilft of H-3 (+δ 1.39), along with the appearance of a
singlet accounting for two protons at δ = 6.95. These preliminary
observations suggested that compound 3 might be a catechin
derivative esterified by gallic acid at C-3. The structure of com-
pound 3 was definitively assigned as (+)-catechin 3-O-gallate
known as (+)-catechin 3-gallate on the basis of comparison of
its spectroscopic data with those given in literature [11].
In vitro cytotoxicity test on mammalian cells
Cytotoxicity was evaluated using human diploid embryonic lung
cell line MRC-5. Cells were obtained from ATCC. They were
maintained for 5 days in culture in the presence of drug and the
cytotoxicity was determined using the colorimetric MTT assay
according to the manufacturer's recommendations (cell prolifer-
ation kit I, Roche Applied Science). The concentration causing
50% of growth inhibition (IC50) was obtained from the drug con-
centration-response curve, and the results were expressed as the
Ramanandraibe Vet al. Antiplasmodial Phenolic Compounds… Planta Med 2008; 74: 417–421